Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea

BACKGROUND/AIMS: This nationwide, multicenter prospective randomized controlled trial aimed to compare the efficacy and safety of 10-day concomitant therapy (CT) and 10-day sequential therapy (ST) with 7-day clarithromycin-containing triple therapy (TT) as first-line treatment for Helicobacter pylor...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Gut Liver
المؤلفون الرئيسيون: Kim, Beom Jin, Lee, Hyuk, Lee, Yong Chan, Jeon, Seong Woo, Kim, Gwang Ha, Kim, Hyun-Soo, Sung, Jae Kyu, Lee, Dong Ho, Kim, Heung Up, Park, Moo In, Choi, Il Ju, Yoon, Soon Man, Kim, Sang Wook, Baik, Gwang Ho, Lee, Ju Yup, Kim, Jin Il, Kim, Sang Gyun, Kim, Jayoun, Lee, Joongyup, Kim, Jae Gyu, Kim, Jae J.
التنسيق: Artigo
اللغة:Inglês
منشور في: Editorial Office of Gut and Liver 2019
الموضوعات:
Original Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6743805/
https://ncbi.nlm.nih.gov/pubmed/31505907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl19136
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة